Testing patterns for risk assessment and adoption of novel therapeies in CLL

 PDF   12/2021

Real-world testing patterns for risk assessment and implications and adaption of novel therapeutics in chronic lymphocytic leukemia: IGHV mutation status,FISH cytogenetic, and immunophenotyping

Rating

Rate this resource